XML 30 R19.htm IDEA: XBRL DOCUMENT v3.19.2
REVENUE
6 Months Ended
Jun. 30, 2019
Revenue from Contract with Customer [Abstract]  
REVENUE REVENUE
Revenue Recognition
Revenues are recognized when control of the promised goods is transferred to customers, in an amount that reflects the consideration the Company expects to realize in exchange for those goods.
The following table presents revenues disaggregated by revenue source. Sales and usage-based taxes are excluded from revenues.
 
 
Three Months Ended
June 30,
 
Six Months Ended
June 30,
 
2019
 
2018
 
2019
 
2018
Product Sales
 
$
152,066

 
$
152,791

 
$
300,016

 
$
305,450

Co-manufacturing
 
6,609

 
8,091

 
13,201

 
13,053

Bill and Hold
 
1,269

 
1,555

 
2,126

 
2,844

Consignment
 
531

 
333

 
1,082

 
1,378

Product Sales Revenue
 
160,475

 
162,770

 
316,425

 
322,725

Royalty Revenue
 
1,079

 
917

 
2,158

 
2,372

Total Revenue
 
$
161,554

 
$
163,687

 
$
318,583

 
$
325,097

The following table presents revenues disaggregated by geography, based on the shipping addresses of customers:
 
 
Three Months Ended
June 30,
 
Six Months Ended
June 30,
 
2019
 
2018
 
2019
 
2018
United States
 
$
122,189

 
$
125,019

 
$
240,300

 
$
245,687

Foreign Countries
 
39,365

 
38,668

 
78,283

 
79,410

Total Revenue
 
$
161,554

 
$
163,687

 
$
318,583

 
$
325,097


Product Sales Revenues
The Company’s primary operation is the manufacturing and sale of health and wellness ingredient products, in which the Company receives an order from a customer and fulfills that order. The Company’s product sales are considered point-in-time revenue and consist of four sub-streams: product sales, co-manufacturing, bill and hold, and consignment.
Under the co-manufacturing agreements, the Company is responsible for the manufacture of a finished good where the customer provides the majority of the raw materials.  The Company controls the manufacturing process and the ultimate end-product before it is shipped to the customer.  Based on these factors, the Company has determined that it is the principal in these agreements and therefore revenue is recognized in the gross amount of consideration the Company expects to be entitled for the goods provided.
Royalty Revenues
Royalty revenue consists of agreements with customers to use the Company’s intellectual property in exchange for a sales-based royalty. Royalties are considered over time revenue and are recorded in the Human Nutrition & Health segment.
Contract Liabilities
The Company records contract liabilities when cash payments are received or due in advance of performance, including amounts which are refundable.
The Company’s payment terms vary by the type and location of customers and the products offered. The term between invoicing and when payment is due is not significant. For certain products or services and customer types, the Company requires payment before the products are delivered to the customer.
Practical Expedients and Exemptions
The Company generally expenses sales commissions when incurred because the amortization period would have been one year or less. These costs are recorded within selling and marketing expenses.
The Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which the Company recognizes revenue at the amount to which it has the right to invoice for products shipped.